Literature DB >> 29447643

A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban.

Riley Dean1, Alison M Messer, Melanie Pickett, Richard Jahan-Tigh.   

Abstract

Cutaneous leukocytoclastic vasculitis (LCV) is type of small vessel vasculitis that commonly presents as palpable purpura involving the lower extremities and buttocks. Approximately half of cases are idiopathic, but the disease may be triggered by infection, drug reaction, inflammatory disease, or other causes. We report a case of leukocytoclastic vasculitis secondary to the novel anticoagulant rivaroxaban (Xarelto®).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29447643

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  2 in total

1.  Apixaban-induced cutaneous leucocytoclastic vasculitis.

Authors:  Munim Khan; Mahmoud Y Madi; Joseph Rencic
Journal:  BMJ Case Rep       Date:  2020-08-24

2.  Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism.

Authors:  Hong Lyeol Lee; Lucia Kim; Cheol Woo Kim; Jung Soo Kim; Hae Sung Nam; Jeong Seon Ryu
Journal:  Respir Med Case Rep       Date:  2019-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.